Position in GILD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$486,408
-$50,166 QoQ
Shares Held
3,850
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,381
of 2,265 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Beacon Bank & Trust holds $15,776,887 across 9 Drug Manufacturers - General names. GILD ranks #5 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,389 | $6,448,043 | |
| 2 | LLY |
ELI LILLY & Co
|
2,885 | $3,460,355 | |
| 3 | MRK |
Merck & Co., Inc.
|
22,741 | $2,922,218 | |
| 4 | ABBV |
AbbVie Inc.
|
4,149 | $1,044,053 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
3,850 | $486,408 | |
| 6 | NVS |
Novartis AG
|
3,076 | $482,070 | |
| 7 | AMGN |
Amgen Inc
|
1,040 | $376,604 | |
| 8 | PFE |
Pfizer Inc
|
14,302 | $344,391 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $486,408 | 3,850 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $536,574 | 3,850 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $472,548 | 3,850 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $434,676 | 3,916 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $450,353 | 4,062 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $423,212 | 3,777 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $313,873 | 3,398 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $275,581 | 3,287 | Shares | Sole | 2024-10-18 | |
| No filing history on record for this holder in this stock. | ||||||